20pc Gerd cases ‘misdiagnosed in UAE’
Dubai, February 23, 2011
Twenty per cent of the cases of gastroesophageal reflux disease (Gerd) are misdiagnosed in the UAE, said the organisers of a recent gastroenterology event in Dubai.
The second annual meeting of the European Association for Gastroenterology and Endoscopy (EAGE) and Emirates Gastroenterology Society took place in the Crown Plaza Dubai Festival City.
The meeting emphasised that symptoms of Gerd, a condition in which the stomach contents leak backwards into the esophagus, need to be correctly diagnosed among patients in the Gulf.
“The conference focused on Gastroesophageal reflux disease (Gerd) in the Gulf and the UAE as a high-incidence disease,” said Dr Fadel Shaker, medical manager, AstraZeneca Gulf.
“We need to create more awareness about Gerd in the UAE. If Gerd is not properly treated, it can lead to serious complications, such as inflammation in the esophagus, narrowing of the esophagus, ulcers and bleeding,” he added.
“AstraZeneca is pleased to sponsor this meeting which aims at improving understanding and diagnosis of Gerd amongst Gulf healthcare professionals and ensure that patients are given the most advanced treatment,” Dr Shaker concluded.
“With the introduction of new drugs and the continuous refinement in diagnostic and therapeutic technology, the field of gastroenterology has witnessed advancement in patient care,” said Dr Adnan Abu Hammour, EAGE course local chairman and former president of the Emirates Gastroenterology Society, who chaired the event.
“Hence, continuous medical education (CME) programmes became part of our commitment towards physicians and patients. In this regard, AstraZeneca pharmaceuticals is providing an educational grant to support continuing Medical education through the second EAGE postgraduate seminar in the Gulf,” said Dr Hammour. – TradeArabia News Service